# Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma

> **NCT00735345** · PHASE2 · TERMINATED · sponsor: **Arbeitsgemeinschaft medikamentoese Tumortherapie** · enrollment: 50 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** 5-FU
- **DRUG:** Cisplatin
- **DRUG:** Taxotere
- **BIOLOGICAL:** Cetuximab
- **RADIATION:** Radiation during chemoradio-immunotherapy

## Key facts

- **NCT ID:** NCT00735345
- **Lead sponsor:** Arbeitsgemeinschaft medikamentoese Tumortherapie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** because of safety concerns the study was terminated prematurely
- **Last updated:** 2015-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735345, "Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00735345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*